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The partitioning of different cholesterol-modified single-stranded DNA molecules (chol-DNAs) between the
domains of phase-separated lipid vesicles is investigated by laser-scanning confocal fluorescence microscopy.
All chol-DNAs studied preferentially localized into the fluid phase of giant vesicles in liquid-solid phase
coexistence (1:1 DLPC:DPPC, 1:1 DLPC:DMPE). Partitioning behavior of chol-DNAs into liquid-liquid
phase-separated vesicles (DOPC/DPPC/cholesterol) was found to be less straightforward. Single-cholesterol-
anchored DNA molecules partitioned roughly equally between coexisting domains, whereas chol-DNAs with
two cholesterol anchors were seen to be enriched in the liquid-ordered domains with apparent surface
concentrations up to double that of the liquid-disordered phase. Quantitative analysis of the fluorescence
intensity of DNA between the two phases also revealed a weaker dependence of the apparent partitioning on
the initial lipid composition of the vesicles. We rationalize these observations by proposing a simple partitioning
model based on the conformational entropy of insertion of a cholesterol anchor into each phase.
Introduction
DNA is a digital, information-carrying molecule by nature’s
design that is attracting much interest for applications in
bionanotechnology.1 Lipid structures, e.g., vesicles, also attract
much technological development as soft, biocompatible contain-
ers for molecular isolation and delivery. Encoding the surface
of these liposomal capsules with information by functionalizing
the membrane with nucleic acid sequences in order to fabricate
“smart” containers has wide-ranging scientific and technological
appeal. Indeed, recent reports have highlighted the utility of
nucleic acid strands modified with hydrophobic moieties as tools
in biotechnological applications.2-26 DNA strands with hydro-
phobic modifications have also been used as model systems for
biological membrane-bound receptors27-29 and membrane fusion
machinery.30-32 The hydrophobic modifications preferentially
associate with lipid bilayers, anchoring the DNA strands to
reconstituted membrane structures such as lipid vesicles or solid-
supported membranes. The anchored DNA is then free to bind
to its complement by the well-known Watson-Crick base pair
interactions, allowing the engineering of components that will
bind with high specificity via their complementary target
sequences.
Membrane-anchored DNA molecules will also allow the
amalgamation between lipid bilayers and DNA nanostructures33,34
and nanomachines.35 The fluid nature of the lipid membrane
would provide a two-dimensional substrate upon which anchored
DNA structures and machines can interact. Current examples
of DNA nanotechnology include molecular switches,36-39
tweezers,40,41 and DNA walkers.42-44 Some future DNA nano-
technology applications may encompass membrane-anchored
nanomachines that function in ways that take inspiration from
the roles of membrane proteins in regulating cellular processes
at its interface with the extracellular environment. Membrane-
anchored DNA molecules could also be employed as aptamers.
Nucleic acid aptamers are oligonucleotides which fold into 3D
structures that bind with high specificity and high affinity to
target molecules.45,46 Anchored DNA aptamers could have
applications in areas such as ligand-targeted drug delivery
systems47-51 or molecular detection assays.
Structural heterogeneity can offer added functionality to
engineered materials. Membrane heterogeneities can be created
by phase separation of coexisting lipid phases. Studies of simple
(when compared to the complexity of natural biomembranes)
two and three lipid component membranes have demonstrated
the coexistence of fluid and solid-like lipid phases52-58 as well
as two coexisting liquid phases referred to as liquid-ordered
and liquid-disordered phases, respectively.59-62 The coexistence
of two distinct surface characteristics in these membranes offers
the possibility of engineering domains with distinct operational
attributes that would allow the exploitation of designed bifunc-
tionality of these lipid structures.
Chemically anisotropic particles on nanoscopic and micro-
scopic length scales have attracted much recent interest, since
such entities can have directional interactions that can be
exploited to assemble a richer array of structural morphologies63,64
and they can also be used to fabricate objects that exhibit
autonomous motion.65 In these respects, anisotropic, functional
lipid vesicles could be engineered to assemble complex super-
structures of vesicle containers encapsulating different chemical
species or as proto-cellular models that exhibit a primitive mode
of chemotaxis.
Coexisting lipid phases are also considered to be minimal
model systems for heterogeneities in natural biomembranes,
often referred to as “lipid rafts”.66-69 These in ViVo lipid domains
are considered to be important for cell signaling processes,
preferentially recruiting or excluding receptors and other
membrane inclusions.70-72 Since membrane-anchored DNA has
been considered as a minimal model for membrane-bound
receptors and vesicle fusion machinery, clustering and local
confinement of these molecules into lipid domains in vesicle
membranes could prove to be a useful tool in exploring potential
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physiological roles of grouping receptors into spatially localized
patches of the membrane. For example, increased local con-
centrations of membrane receptors by clustering into domains
is thought to increase the binding affinity of individually weak
ligand-receptor bonds.73
With these motivations in mind, we use fluorescence confocal
microscopy to investigate the partitioning of DNA with hydro-
phobic modifications between coexisting lipid phases. We
investigate the effect of the choice of membrane-anchoring
geometry on DNA localization in giant vesicles with domains
of solid-like phases (L or P′) within a fluid (LR) matrix as
well as membranes in liquid-ordered (Lo)-liquid-disordered (LR)
coexistence (note that the liquid-disordered phase is also
commonly denoted Ld in the literature). The hydrophobic
anchors we investigate in this work are all based on com-
mercially available cholesteryl modifications, since their current
ease of availability makes them the most accessible for wide
use in scientific and engineering applications without the need
for specialist skills in synthetic chemistry and DNA synthesis.
Methods
Materials. The lipids 1,2-dilauroyl-sn-glycero-3-phospho-
choline (DLPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-
dimyristoyl-sn-glycero-3-phosphoethanolamine (DMPE), and
cholesterol (chol) were purchased from Avanti Polar Lipids.
The lipophilic fluorophores Lissamine rhodamine B 1,2-dihexa-
decanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium
salt (Rh-DPPE) and 2-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-
diaza-s-indacene-3-pentanoyl)-1-hexadecanoyl-sn-glycero-3-
phosphocholine (Bodipy-PC) were purchased from Invitrogen
Molecular Probes. Cholesterol-modified oligonucleotides (chol-
DNA) cholesteryl-TEG-5′-ACAGACTACC-3′ (chol-DNA-
10A), cholesteryl-TEG-3′-TTTGGCCCGCGCCCCGCCCC-5′
(chol-DNA-20), cholesteryl-TEG-5′-TTTCCGGGCGCGGGGCG-
GGGACAGACTACC-3′ (chol-DNA-30A), and parallel-cho-
lesteryl-TEG-cholesteryl-TEG-5′-ACAGACTACC-3′ (2p-chol-
DNA-10A) were purchased from Eurogentec North America
and had been purified by HPLC. Fluorescently labeled DNA
Alexa Fluor 647-5′-GGTAGTCTGT-3′ (A647-DNA-10B) was
purchased from IDT and had also undergone HPLC purification.
Vesicle Preparation. Giant unilamellar vesicles (GUVs) were
formed by electroformation. Lipid stock solutions in chloroform
were made up at the desired molar ratio to a total lipid
concentration of 1.0 mM. A 70 µL portion of lipid in chloroform
solution was placed dropwise onto the platinum wires of the
electroformation chamber and dried under a vacuum for at least
4 h. A preheated 300 mM aqueous sucrose solution was added
to the electroformation chamber in an oven at a temperature in
excess of 50 °C such that all lipids were in the fluid phase. A
3.0 V ac field was applied across the platinum wires at 10 Hz
for 30 min, 3.0 Hz for 15 min, 1.0 Hz for 7 min, and 0.5 Hz for
7 min. The vesicles were then removed from the chamber. Chol-
DNA dissolved in 125 mM NaCl, 10 mM Hepes (pH 7.4) was
added to the GUV solution at a DNA:lipid ratio of <0.01; 163
mM NaCl, 10 mM Hepes (pH 7.4) was also added to the
solution to give a final NaCl concentration of 110 mM. Either
the addition of these solutions was done prior to phase separation
at 50 °C, and this temperature was maintained for at least 30
min to allow chol-DNA to diffuse into the membranes before
cooling, or the addition of these solutions was done after cooling
to room temperature, i.e., after lipid phase separation, where
the samples were again left for 30 min to ensure membrane
association of the chol-DNA. Once samples had cooled to room
temperature and chol-DNA was incorporated in the vesicles, a
solution of A647-DNA-10B was added at a 1:1 ratio with chol-
DNA; the samples were left for a minimum of 30 min to allow
the fluorescently labeled DNA to hybridize with the membrane-
anchored DNA before imaging.
Confocal Microscopy. GUVs were imaged using the Leica
TCS SP5 confocal system equipped with a Leica 63×/1.3 N.A.
Plan Apo DIC Glycerin immersion objective lens. The Rh-DPPE
probe was excited by a DPSS laser at 561 nm, the Bodipy-PC
probe was excited with the 488 nm line of an argon laser, and
the Alexa Fluor 647 was excited by a helium-neon laser at
633 nm. The photomultiplier tubes were offset such that the
black level was zero across most of the sample before beginning
experiments; variations in black level were, at worst, (2 au
across the image. Glass bottom culture dishes (MatTek Corpora-
tion, part no. P35G-1.5-20-C) were treated with a 10% Bovine
Serum Albumin (Sigma) solution prior to use in order to prevent
the vesicles from adhering to the glass coverslip. All vesicles
were imaged at room temperature, approximately 21 ( 1 °C.
Results and Discussion
We investigate the partitioning of three different chol-
modified DNAs between coexisting lipid membrane phases. The
three molecular geometries under investigation are shown in
Figure 1. First, there is a single-chol-modified DNA (chol-DNA-
10A). Second, there are two single-chol-modified DNAs (chol-
DNA-20/chol-DNA-30A) where the chol-DNA-20 hybridizes
to what will be the membrane-proximal portion of the chol-
DNA-30A leaving an overlapping section of the chol-DNA-
30A which can bind to complementary target sequences. This
hybridized DNA pair results in a molecule with double-chol
anchoring into lipid membranes, increasing the strength of
membrane binding for longer DNA sequences. Finally, we test
a double-chol-modified DNA (2p-chol-DNA-10A), where the
two chol moieties are positioned parallel to one another by a
symmetric spacer modification on the 5′ end of the DNA strand.
We study the partitioning of chol-DNA-10A and chol-DNA-
20/chol-DNA-30A in vesicles exhibiting solid-fluid phase
coexistence and the partitioning of all three chol-modified DNA
geometries in vesicles in liquid-liquid phase coexistence. We
directly visualize the chol-DNA partitioning in the vesicle
membranes by confocal fluorescence microscopy which yields
thin image sections through the vesicles highlighting the
locations of fluorescent probes within the lipid membrane.
Fluorescent lipids are used to mark the locations of the different
lipid phases, while a water-soluble, fluorescent DNA (A647-
DNA-10B) which is complementary to the chol-DNAs is added
to the samples to elucidate the partitioning of the membrane-
bound nucleic acids. This fluorescent DNA binds specifically
to the chol-DNA, and the distribution of its fluorescence signal
within the membrane can be resolved by the confocal micro-
scope (see Figure 2). Note that control experiments where the
fluorescent DNA was added to samples of GUVs that were not
functionalized by chol-DNAs did not detect any nonspecific
binding of the A647-DNA-10B to the membranes. Image
sections obtained by confocal microscopy can be reconstructed
to reveal the vesicle surface textures created by phase separation.
Fluid-Solid Phase-Separated Vesicles. The partitioning of
chol-modified DNAs in 1:1 DLPC:DPPC giant unilamellar
vesicles (GUVs) at room temperature was investigated. These
vesicles contain coexisting LR fluid and P′ solid phases. The
P′ phase forms stripe-like domains templated by the anisotropic
line tension of the corrugated ripples of the molecular-scale
structure of this phase (Figure 3A,B):55,56 in these images, the
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Bodipy-PC dye (green) partitions preferentially into the fluid
phase and Rh-DPPE (red) enriches in the solid-like P′ phase.
Figure 3C-F shows single confocal sections through the equator
of these vesicles where A647-DNA-10B (blue), and hence the
chol-DNA, is observed to have localized preferentially to the
fluid LR regions of the membrane. The chol-DNA (single-chol-
anchored chol-DNA-10A or double-chol-anchored chol-DNA-
20/chol-DNA-30A) was always observed to partition preferen-
tially into the fluid phase of these vesicles regardless of whether
the vesicles were functionalized with chol-DNA before or after
the membrane phase separated; i.e., no history dependence was
observed in the chol-DNA partitioning.
We also investigated the partitioning of chol-DNA in
fluid-solid phase-separated vesicles where the solid-like phase
has a flat, lamellar structure as opposed to the rippled structure
of the P′ phase. 1:1 DLPC:DMPE vesicles phase separate into
coexisting LR fluid and L solid-like phases. The L phase is
thought to have no long-range molecular ordering on optically
resolvable length scales. On slow cooling, these domains form
circular domains which ripen by limited coalescence due to the
slow molecular diffusion in the solid-like phase on experimental
time scales, upon which further domain growth occurs.54-56 This
results in surface textures exemplified in Figure 4A1, B1, C1,
and D1; these images show the morphologies of vesicle
hemispheres that have been reconstructed from the confocal
image slices. In these images, Rh-DPPE (red) partitions into
the fluid phase, leaving the L solid phase to appear dark. Figure
4A2, B2, C2, and D1 reveals the partitioning of chol-DNA
between the fluid and solid-like phases. As in the previous case
of DLPC/DPPC vesicles, both the single-anchored chol-DNA-
10A and the double-anchored chol-DNA-20/chol-DNA-30A
were preferentially found to be located in the LR fluid phase;
no significant fluorescent signal from the A647-chol-10B could
be detected in the solid-like L domains. This preference of the
chol-DNA partitioning was not affected by the addition of the
chol-DNA prior to or after phase separation in the vesicle’s
membrane in sample preparation.
The single- and double-chol anchoring of DNA to lipid
membranes in solid-fluid phase coexistence always resulted
in the DNA functionality partitioning into the fluid phase of
the systems that we investigated. This comes as little surprise,
since impurities are normally expected to partition into the less
ordered of the two phases, since it is rare for molecular additives
to have a lower free energy cost by inserting into phases with
a higher molecular ordering, e.g., the enrichment of Rh-DPPE
in the P′ phase of vesicles in LR-P′ coexistence. However,
these systems do demonstrate that asymmetric distributions of
membrane-anchored DNA can easily be fabricated by engineer-
ing the lipid composition such that the membrane phase
separates into coexisting fluid and solid-like phases. Further-
more, by selection of the particular solid-like lipid phase that
forms, different domain morphologies are attainable: therefore,
this allows a degree of control over the resulting texture of the
DNA surface distribution.
While an asymmetric distribution of membrane-anchored
DNA is attainable by solid-liquid phase separation, these
systems may have limitations depending on the intended
application. For example, it would be difficult to find a second
hydrophobic anchor that would partition into the solid domains
in order to anchor a second DNA sequence in the opposite
domains to create bifunctionalized vesicles. Furthermore, solid
domains place certain restrictions on the resultant morphological
distribution of domains. Therefore, we study the partitioning
Figure 1. Chol-modified DNA structures: (A) chemical structure of a single-chol modification for a single-stranded DNA (ssDNA) molecule
(DNA chemical structure is not drawn); (B) chemical structure of a double-chol modification for ssDNA molecules (two cholesteryl TEG molecules
linked by a symmetric branched modification); (C) cartoon of single-chol-modified ssDNA anchoring the DNA molecule to a lipid bilayer (e.g.,
chol-DNA-10A); (D) cartoon of two single-chol-modified ssDNA molecules that hybridize together to create a double-chol anchor, leaving an
overlapping sequence that is free to bind complementary targets (e.g., chol-DNA-20/chol-DNA-30A); (E) cartoon of a double-chol-modified ssDNA
anchored to a lipid membrane (e.g., 2p-chol-DNA-10A).
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of chol-DNAs between coexisting liquid phases to investigate
whether such systems might overcome some of these limitations.
Liquid-Liquid Phase-Separated Vesicles. Ternary vesicles
composed of a saturated lipid, an unsaturated lipid, and
cholesterol can phase separate into coexisting liquid phases, e.g.,
DOPC/DPPC/chol.61,62 Deuterium NMR studies of this system
reveal the thermodynamic tie lines along which the membranes
phase separate and show that the liquid-ordered phase (Lo) is
rich in DPPC and chol and the liquid-disordered phase (LR) is
rich in DOPC and has a lower chol composition.74 A first order
assumption might be that the cholesteryl moieties of the chol-
DNA molecules will therefore enrich in the Lo phase of these
vesicles. However, it is well established that probes designed
as cholesterol mimics usually do not satisfactorily reproduce
the properties of pure cholesterol.75,76 Small changes to the
structure of cholesterol can have a significant influence on the
properties, composition, and location in phase space of coexist-
ing lipid domains, as has been demonstrated by experiments
where cholesterol is replaced by structurally similar sterols as
the third major constituent of ternary GUVs.77,78 Indeed, we are
aware of four different fluorescently labeled cholesterol mol-
ecules whose partitioning between coexisting liquid phases has
been investigated: three of these modified cholesterols prefer-
entially segregated into LR domains, while the fourth enriched
in the Lo phase.79,80 Therefore, the chol-DNAs cannot be
assumed to partition in the same proportions as chol between
these coexisting phases, since the perturbations in structure of
chol-DNA from that of pure chol will have some significance
in the molecular insertion into each phase.
We find that the nature of the cholesteryl anchoring geometry
affects the partitioning of chol-DNA between coexisting liquid
phases. Figure 5A,B shows the partitioning of single-anchored
chol-DNA-10A labeled with A647-DNA-10B (blue) between
coexisting liquid phases, where the LR phase is highlighted by
inclusion of the Rh-DPPE dye (red). Compare these images to
Figure 5C,D where the vesicles are instead functionalized by
the double-anchored chol-DNA-20/chol-DNA-30A pair: the
single-anchored chol-DNA is seen to partition roughly equally
between the two phases, whereas the double-anchored chol-
DNA is enriched in the Lo phase compared to the LR domains.
The relative concentrations of chol-DNA in the two liquid
phases can be investigated by quantitative analysis of the
fluorescence intensity of A647-DNA-10B in each phase. Figure
6 shows a single confocal image slice through the equator of a
1:1:1 DOPC:DPPC:chol GUV functionalized by double-
anchored chol-DNA-20/chol-DNA-30A. We choose to analyze
image sections at the equator of the vesicles because, in image
sections near the poles of the vesicle, the membrane area per
pixel is not constant due to the spherical curvature of the vesicle.
A line profile (green) across the vesicle that crosses both the
LR and Lo phases is shown; the intensity profiles as a function
of distance along this line section in the two fluorescence
channels are shown to the right of the image. From these graphs,
the peak intensities of A647-DNA-10B fluorescence can be
obtained for each phase, the ratio of which is a measure of the
apparent partitioning (Kpa) of chol-DNA between the two phases,
i.e., I647(Lo)/I647(LR) ) Kpa, where I647(Lx) is the peak intensity
of A647-DNA-10B in the Lx phase.
Figure 2. Cartoon of the experimental setup. The partitioning or
membrane-anchored DNA is visualized by observing where on the
membrane a fluorescently labeled complementary strand binds.
Figure 3. Giant vesicles in LR-P′ phase coexistence. Red represents
Rh-DPPE (the P′ phase), green represents Bodipy-PC (the LR phase),
and blue represents Alexa-647 (DNA). (A, B) Reconstructions of vesicle
hemispheres demonstrating the characteristic stripe morphology of ripple
phase domains in GUVs. (C, D) Single confocal slices through the
equator of a vesicle: (C) lipid phase probes; (D) DNA probe. (E, F)
Single confocal slices through the equator of a vesicle that has been
deformed from its native spherical geometry by the growth of the solid-
like ripple phase domains: (E) lipid phase probes; (F) DNA probe. All
vesicles are 1:1 DLPC:DPPC at 21 ( 1 °C.
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Care must be taken in interpreting relative fluorescence
intensities in confocal images, for example, due to possible
variations in fluorophore quantum yield between coexisting
phases, as has previously been noted.80 However, in our
experiments, the fluorescent probe is extended several nano-
meters from the bilayer by double-stranded DNA and thus the
fluorophore itself will not experience the difference in local
membrane environments between coexisting lipid phases;
therefore, the local environment of the fluorophore will be the
bulk aqueous phase irrespective of which phase the chol-DNA
resides in and therefore we do not anticipate any differences in
the quantum yield of the probe between phases. Also, we use
low chol-DNA concentrations (<1% total lipid concentration)
such that we do not anticipate any self-quenching of the
fluorescent probe. Probe partitioning between phases is usually
measured by bulk fluorescent spectroscopy experiments. How-
ever, for three component systems, the directions of the tie lines
within the phase diagram need to be known. Only a few tie
lines have been quantitatively reported for this system,74 and
these tie lines have significant error bars such that these errors
would hinder the analysis of bulk partitioning data. Therefore,
no bulk spectroscopy measurements of the true partitioning
coefficients (Kp) for chol-DNA between coexisting liquid phases
are available to compare with the apparent partitioning (Kpa)
we measure from our confocal images. By analyzing several
line profiles per vesicle over many vesicles in at least two
independent sample preparations, a statistical measurement of
the apparent partitioning of chol-DNA between the two phases
is obtained.
We quantify the apparent partitioning of the three chol-DNA
structures in vesicles of two different lipid compositions in the
liquid-liquid coexistence region of DOPC/DPPC/chol mem-
branes (Table 1). The effect of sample history (whether the
vesicles were functionalized with DNA before or after phase
separation was initiated) does not appear to have a significant
effect on the chol-DNA partitioning between phases, since the
apparent concentration ratios measured are comparable when
taking into account the uncertainty in the data. This is therefore
a good indication, but not proof, that we are measuring near-
equilibrium partitioning of the chol-DNAs.
Double-chol anchoring of the DNA to the membrane en-
hances the partitioning of both the chol-DNA-20/chol-DNA-
30A and 2p-chol-DNA-10A into the Lo phase compared to that
of the single-anchored chol-DNA-10A. This suggests that the
two chol moieties per molecule play a significant role in
determining the enrichment of these chol-DNAs in the more
ordered of the two phases. We do also note that the double-
chol moiety is not the sole determinant of the chol-DNA
partitioning, since there is a small but significant difference in
the apparent partitioning of these two different double-anchored
chol-DNA molecules between the liquid phases, where the
enrichment of chol-DNA-20/chol-DNA-30A into Lo domains
is greatest: other structural factors must fine-tune the exact
distribution between the phases. However, our data suggests
that the number of cholesterol anchors is the most significant
determinant for the observed partitioning. Single-chol-anchored
DNA partitions roughly equally between phases with only a
small 10-20% apparent enhancement in the Lo phase, whereas
enrichment of double-anchored chol-DNA in Lo domains such
that the apparent concentration is approximately double that of
the LR phase was achievable in these systems.
The lipid composition of the GUVs also modulates the
segregation of the chol-DNAs between phases. The data in Table
1 clearly shows that the enrichment of double-anchored chol-
DNAs into the Lo phase is greater for 1:1:1 DOPC:DPPC:chol
vesicles than GUVs composed of these lipids in the molar ratio
3:3:2. This is not particularly surprising, since vesicles of a
different composition will phase separate along different
thermodynamic tie lines, resulting in different compositions for
each phase for these two different lipid mixtures. Membrane
domains of different lipid compositions will have different
properties; for example, increased chol compositions are known
to increase rigidity and reduce fluidity of lipid membranes,81
while these effects are now known not to be universal but
dependent on the molecular structure of the lipid(s), e.g., the
degree of chain unsaturation, in the membrane into which
cholesterol is added.82 The composition and properties of the
domains will therefore determine the exact partitioning of the
chol-DNAs between the coexisting phases.
Figure 4. Giant vesicles in LR-L phase coexistence. All vesicles are
1:1 DLPC:DMPE at 21 ( 1 °C. (A-D) Images are reconstructions of
vesicle hemispheres from confocal sections. Images numbered 1 show
Rh-DPPE partitioning (the LR phase), and images numbered 2 show
Alexa-647 (DNA) partitioning.
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The partitioning of the chol-DNA between lipid domains is
determined by the free energy cost of insertion of these
molecules into the respective phases. In thermodynamic equi-
librium, the concentrations of chol-DNA in each phase are
established by Kp ) c(Lo)/c(LR) ) exp{-∆G(T)/kBT}, where
c(Lx) is the concentration of chol-DNA in the Lx phase, ∆G(T)
is the difference in Gibbs free energy for molecular insertion
into the two phases, kB is Boltzmann’s constant, and T is the
temperature. Therefore, to attempt to understand the enhanced
partitioning of the double-anchored chol-DNA in Lo domains,
it is necessary to consider how the free energy of insertion into
the respective phases might be modulated by having an extra
chol anchor.
We propose a simple model based upon the conformational
entropy of insertion of a chol anchor into each phase in order
to rationalize the observation that molecules with two anchors
partition more strongly into the Lo phase. Pure cholesterol has
been measured to partition roughly twice as much into the Lo
phase than the LR phase for 1:1 DOPC:DPPC vesicles with 30%
chol at 25 °C,74 demonstrating a lower chemical potential for
molecular insertion of cholesterol into the Lo phase (it should
be noted however that the exact quantitative partitioning of chol
between coexisting phases will depend on the particular tie line
along which the vesicle phase separates, i.e., the specific
temperature and membrane composition). The single-anchored
chol-DNA still shows a slight apparent enhancement in the Lo
phase by around 10-20% which implies that this molecule has
a lower free energy benefit for partitioning into the Lo phase
than pure chol. This is likely to be due to the free energy cost
due to the imposition of the TEG linker to the DNA strand
through the headgroup region of the membrane being greater
in the more ordered Lo phase, although we cannot discount an
additional energy cost due to the rigid double-stranded DNA
that extends into the aqueous phase outside of the lipid bilayer.
The preference of chol to partition more strongly into the
DPPC-rich Lo phase as opposed to the DOPC-rich LR phase is
thought to be at least partially due to the difficulty of insertion
of the rigid fused-ring structure of the sterol next to the
unsaturated acyl chains of the DOPC, which cause its hydro-
phobic tails to kink. This is exemplified by the finding that chol
prefers to lie flat in the center of membranes composed of highly
unsaturated lipids as opposed to its usual “upright” location with
the hydroxyl group situated near the amphiphilic interface with
hydrophilic headgroups of the lipids.83,84 This unfavorability of
locating the chol moiety next to the unsaturated DOPC will
reduce the number of possible conformations that chol can insert
into the LR phase compared to the Lo domains. If we assume
that the chol anchor can insert n ways into the LR phase and qn
ways into the Lo phase, where q (>1) represents the proportional
increase in possible conformations that the chol anchor can insert
into the Lo phase than the LR phase, then the conformational
entropy difference between insertion into the two phases for a
single-cholesterol anchor is ∆Ssingle ∝ ln q. In the case of two
Figure 5. Giant vesicles in Lo-LR phase coexistence. All vesicles are 1:1:1 DOPC:DPPC:chol at 21 ( 1 °C. (A-D) Images are reconstructions
of vesicle hemispheres from confocal sections. Images numbered 1 show Rh-DPPE partitioning (the LR phase), and images numbered 2 demonstrate
Alexa-647 (DNA probe) partitioning. (A, B) Vesicles are functionalized with single-cholesterol-anchored DNA (chol-DNA-10A). (C, D) Vesicles
are functionalized with double-cholesterol-anchored DNA (chol-DNA-30A/chol-DNA-20).
Figure 6. (left) Separate fluorescence channels and channel overlay
of a confocal slice through the equator of a 1:1:1 DOPC:DPPC:chol
vesicle functionalized with double-anchored DNA (chol-DNA-30A/
chol-DNA-20) and A647-DNA-10B. Red represents Rh-DPPE (the LR
phase), and blue represents Alexa-647 (DNA probe). The green line
represents a line section through the vesicle of which the intensity
profiles for each channel are shown (right).
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chol anchors per molecule, we can make the first order
assumption that the number of ways each chol can insert into
each phase is not influenced by being tethered to each other;
i.e., the conformational freedom of two chol anchors for
insertion into each phase is not coupled. Then, for the LR phase,
the first chol anchor can insert n ways into the phase and the
second chol anchor can also insert in n ways at a nearby location
in this phase, such that the double-anchored molecule can insert
in n2 ways into the LR phase. Similary, for the Lo phase, the
double-chol-anchored molecule can then insert in q2n2 ways,
resulting in a conformational entropy difference for molecular
insertion into the two phases of ∆Sdouble ∝ 2 ln q. Therefore,
the difference in conformational entropy gain for insertion into
the Lo phase, ∆∆S ) ∆Sdouble - ∆Ssingle ∝ ln q, means that there
is an increase in conformational entropy gain for insertion of
the double-chol-anchored DNA into the Lo phase, thereby
enhancing this molecule’s partitioning into these domains.
We note that if there is some coupling between the two chol
moieties due to being tethered together into the same molecule
such that insertion of the first anchor restricts the number of
conformations by which the second can insert, then ∆Sdouble ∝
r ln q, where 1 < r < 2; this still predicts an enhanced partitioning
of the double-anchored chol-DNA into the Lo phase compared
to that of the single-chol variant. Indeed, a difference in such a
coupling between the chol moieties of the chol-DNA-20/chol-
DNA-30A and 2p-chol-DNA-10A due to the details of their
linker chemistry could explain the slight differences in partition-
ing observed for these molecules; the first three bases of the
chol-DNA-20/chol-DNA-30A are noncomplementary and hence
do not hybridize, which is likely to reduce any conformational
coupling effects between the two chol anchors for this molecule.
While this very simple model based upon changes in
molecular conformational entropy predicts the phenomenon of
enhanced partitioning of the double-anchored chol-DNA into
the Lo domains, a full thermodynamic description of the
observed partitioning would involve consideration of the both
entropic and enthalpic contributions to the free energy of
insertion. Formulation of such a model is likely to be challeng-
ing, since cholesterol-lipid interactions are known to be
complex. These interactions are known to be sensitive to the
specific structure of the lipids,82 and several models exist for
the molecular behavior of chol in lipid phases, including the
“umbrella model”85 and models based upon the formation of
condensed lipid-chol complexes.82,86,87
The enrichment of the double-anchored DNA molecules in
the Lo domains could be used to create selectively sticky patches
on the vesicle surface. Figure 7 shows a liquid-liquid phase-
separated GUV functionalized with chol-DNA-20/chol-DNA-
30A; note that the morphology of the domains in these vesicles
ripens to a single domain by coalescence, reducing the line
tension between phases. This two-faced texture is analogous to
that of “Janus particles”.88 We have previously reported a phase
diagram for GUV binding mediated by DNA functionalization
with varying DNA surface concentration and solution ionic
strength,27 where the precise quantitative location of the phase
boundaries will also be dependent on the DNA sequence used.
A cartoon of such a phase diagram is illustrated in the bottom
right of Figure 7; the phase boundary drawn indicates a transition
between no vesicle adhesion and vesicle adhesion mediated by
specific binding of cDNA sequences. Since double-anchored
chol-DNAs show an apparent enrichment to approximately twice
the surface concentration in the Lo phase compared to the LR
phase, the system could be engineered such that the DNA
concentration in the Lo phase favors adhesion and the concentra-
tion in the LR phase does not, as shown in Figure 7. This would
break the spherical symmetry of intervesicle interactions,
introducing directional binding. Experimental realization and
investigation of preferential adhesion between the Lo domains
of such vesicles will be a subject of future work in our lab.
Furthermore, introducing a second DNA sequence with a
different hydrophobic modification which anchors the DNA
preferentially in the LR phase would allow fabrication of
domains functionalized by different nucleic acid sequences. Such
a modification has been reported by Bunge et al.6,9 Investigation
of the phase partitioning of different hydrophobic modifications
for DNA will provide a toolbox for the fabrication of multi-
TABLE 1: Ratio of the Average Fluorescence Intensities from A647-DNA-10B in Coexisting Liquid Phases, I(Lo)/I(Lr), for
Different GUV Compositions, Sample Histories, and Hydrophobic Anchoring Geometries
1:1:1 DOPC:DPPC:chol 3:3:2 DOPC:DPPC:chol
membrane-anchored
DNA
chol-DNA added before
phase separation
chol-DNA added after
phase separation
chol-DNA added before
phase separation
chol-DNA added after
phase separation
single anchor (chol-DNA-10A) 1.32 ( 0.10 1.19 ( 0.09 1.12 ( 0.05 1.18 ( 0.08
double anchor (chol-DNA-20/
chol-DNA-30A)
1.94 ( 0.16 2.09 ( 0.17 1.68 ( 0.14 1.76 ( 0.14
double anchor (2p-chol-DNA-10A) 1.78 ( 0.13 1.98 ( 0.11 1.56 ( 0.07 1.66 ( 0.07
Figure 7. Selectively sticky DNA domains on liquid-liquid phase-
separated GUVs. 1:1:1 DOPC:DPPC:chol GUV functionalized with
chol-DNA-20/chol-DNA-30A: Rh-DPPE emission (top left), A647-
DNA-10B emission (top right), composite image (bottom left). (bottom
right) Cartoon of a phase diagram for DNA-functionalized GUVs with
varying DNA surface concentration and solution ionic strength based
on the phase diagram in ref 20. DNA partitioning in phase-separated
GUVs could be engineered such that only the DNA surface concentra-
tion in the Lo phase is high enough for binding with complementary
sequences at the solution ionic strength (as shown by the data points
signifying DNA concentrations in the two phases: one above and one
below the phase boundary for vesicle aggregation).
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functional textured vesicles tailored for specific technological
applications.
Summary
We have investigated the partitioning of different hydropho-
bically modified DNAs based upon cholesterol anchoring
between different coexisting lipid phases. All chol-DNAs tested
were essentially excluded from solid-like lipid domains that
formed in fluid vesicle membranes irrespective of the specific
molecular packing structure of the solid phase. Partitioning of
chol-DNAs between coexisting liquid domains was found to
be more complex with a detectable fluorescence signal in each
phase due to the localization of the chol-DNA within the
membrane. The quantitative apparent partitioning of the chol-
DNA is seen to be dependent on the details of the molecular
structure of the chol-DNA and the precise lipid composition of
the coexisting domains. The most significant modulation of chol-
DNA partitioning is observed when two cholesterol anchors are
used instead of a single-chol moiety: double-chol anchoring
enhanced the chol-DNA partitioning into the Lo phase. We
interpret this observation in terms of the conformational entropy
of insertion of a chol anchor into each phase, where the rigid
sterol structure can access fewer conformational states due to
the “kinks” in the acyl chains of DOPC in the LR phase. These
results demonstrate that lipid phase separation is an effective
tool to engineer asymmetric distributions of anchored DNA
molecules on a vesicle surface. Vesicle domains encoded with
information in the form of anchored nucleic acid sequences may
fill roles as intelligent, soft containers in biotechnology.
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